EUVIMEDEUVIMED entdecken
Crossref

Blockade of purine metabolism reverses macrophage immunosuppression and enhances anti-tumor immunity in non-small cell lung cancer

Li Yang, Aitian Li, Weina Yu, Huishang Wang, Lei Zhang, Dan Wang, Ying Wang, Ru Zhang, Qingyang Lei, Zhangnan Liu, Shanshan Zhen, Haiming Qin und 4 weitere

Drug Resistance Updates · 2025-01 · 78 · 101175

DOI: 10.1016/j.drup.2024.101175 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2025-01. Verfasst von Li Yang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China; State Key Laboratory of Esophage…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Purines, Tumor Microenvironment. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: Immune checkpoint blockade therapy is not effective in most patients with non-small cell lung cancer (NSCLC) due to the immunosuppressive tumor microenvironment. Macrophages are key components of tumor-infiltrating immune cells and play a critical role in immunosuppression, which can be mediated by cell-intrinsic metabolism. This study aimed to evaluate whether macrophages regulate NSCLC progression through metabolic crosstalk with cancer cells and affect immunotherapy efficacy. METHODS: The macrophage landscape of NSCLC tissues were analyzed by single-cell sequencing and verified through flow cytometry and immunofluorescence. Multiplex assay, single-cell sequencing data, ELISA, immunofluorescence, and RNA-seq et al. were used to investigate and verify the mechanism of macrophage-mediated metabolic regulation on immunosuppression. The tumor-bearing model was established in C57BL/6 J mice to explore in vivo efficacy. RESULTS: We found that tumor tissue-derived macrophages exhibited an anti-inflammatory phenotype and had a prognostic value for NSCLC. NSCLC cell-secreted CXCL8 recruited macrophages from peritumor tissues to tumor sites and promoted programmed death-ligand 1 (PD-L1) expression by activating purine metabolism with increasing xanthine dehydrogenase and uric acid production. Moreover, purine metabolism-mediated macrophage immunosuppression was dependent on NLRP3/caspase-1/IL-1β signaling. Blockade of purine metabolism signaling enhanced anti-tumor immunity and the efficacy of anti-PD-L1 therapy. CONCLUSIONS: Collectively, our findings reveal a key role of purine metabolism in macrophage immunosuppression and suggest that blockade of purine metabolism combined with immune checkpoint blockade could provide synergistic effects in NSCLC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsPurinesTumor MicroenvironmentMice, Inbred C57BLMacrophagesAnimalsHumansMiceImmune Checkpoint InhibitorsCell Line, TumorTumor-Associated MacrophagesImmunotherapy

Stichwörter der Autor:innen

CXCL8Immune checkpointNSCLCPurine metabolismTAMs

Substanzen

PurinesImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou, Henan, China; School of L…
  • Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Thoracic Surgery Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Department of Radiotherapy, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China. Electronic address: songxianlu@tom.com.

Zitieren

APA

Yang, L., Li, A., Yu, W., Wang, H., Zhang, L., Wang, D., Wang, Y., Zhang, R., Lei, Q., Liu, Z., Zhen, S., Qin, H., Liu, Y., Yang, Y., Song, X. L., & Zhang, Y. (2025). Blockade of purine metabolism reverses macrophage immunosuppression and enhances anti-tumor immunity in non-small cell lung cancer. Drug Resistance Updates, 78, 101175. https://doi.org/10.1016/j.drup.2024.101175

Vancouver

Yang L, Li A, Yu W, Wang H, Zhang L, Wang D, et al. Blockade of purine metabolism reverses macrophage immunosuppression and enhances anti-tumor immunity in non-small cell lung cancer. Drug Resistance Updates. 2025;78:101175. doi:10.1016/j.drup.2024.101175

BibTeX
@article{Yang2025,
  author = {Yang, Li and Li, Aitian and Yu, Weina and Wang, Huishang and Zhang, Lei and Wang, Dan and Wang, Ying and Zhang, Ru and Lei, Qingyang and Liu, Zhangnan and Zhen, Shanshan and Qin, Haiming and Liu, Yaqing and Yang, Yang and Song, Xian-Lu and Zhang, Yi},
  title = {Blockade of purine metabolism reverses macrophage immunosuppression and enhances anti-tumor immunity in non-small cell lung cancer},
  journal = {Drug Resistance Updates},
  year = {2025},
  volume = {78},
  pages = {101175},
  doi = {10.1016/j.drup.2024.101175}
}
Kostenlos starten →